Natco Pharma Limited (NSE: NATCO PHARM) receives tentative approval from U.S. FDA for Olaparib tablets, bioequivalent to Lynparza.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA tentative approval for Larotrectinib Capsules, marking a significant milestone.